CSS
OKUR

Cubist Systematic Strategies’s OnKure Therapeutics OKUR Stock Holding History

Cubist Systematic Strategies’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,549
Closed -$177K – 3649
2024
Q4 		$177K Buy
20,549
+20,496
+38,672% +$310K ﹤0.01% 2606
2024
Q3 		$906 Sell
53
-330
-86% -$4.88K ﹤0.01% 2894
2024
Q2 		$5.78K Buy
+383
New +$6.49K ﹤0.01% 2821
2024
Q1 		– Sell
-96
Closed -$1.54K – 4368
2023
Q4 		$1.54K Buy
+96
New +$5.98K ﹤0.01% 3462

Other funds holding OKUR

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Cubist Systematic Strategies's OKUR Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of OnKure Therapeutics (OKUR) in Q1 2025, closing a stake of 20,549 shares — an estimated $177K sold.

Cubist Systematic Strategies first reported a position in OKUR in Q4 2023 and held it in 4 quarters. The position peaked at $177K in Q4 2024. 47 funds tracked by Wall St. Rank hold OKUR as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining OnKure Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 20,549 OnKure Therapeutics shares in Q1 2025, an estimated $177K.
  • Cubist Systematic Strategies first reported a position in OnKure Therapeutics in Q4 2023 and held it in 4 quarters.
  • Cubist Systematic Strategies's OnKure Therapeutics position peaked at $177K in Q4 2024.
  • 47 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.